arrow_rightarrow_righticon_excelicon_pficon_ppticon_wordmagnifier

Programme

Thursday 07 Jun

Thursday 07 June 2018

08:30

Registration

09:00

Welcome

Henk Hartgrink, Leiden, The Netherlands

Session 1 Diagnostic modalities

Chairs: Franco Roviello & Johanna van Sandick

09:05

L1.1 Role of FDG-PET in gastric cancer

Lioe-Fee de Geus - Oei, Leiden, The Netherlands

09:25

L1.2 Role of MRI in detection of peritoneal metastases in gastric cancer staging

Max LaHaye, NKI Amsterdam, The Netherlands

09:45

L1.3 Diagnostic laparoscopy and peritoneal lavage for gastric cancer staging

Giovanni de Manzoni, Verona, Italy

10:05

S01 Relation between Preoperative Imaging Assessment of Neoadjuvant Chemotherapy and Pathological Response in Gastric Cancer

Zhigang Xue, Beijing, China

10:15

Break

Session 2 Surgery

Chairs: Giovanni de Manzoni & Jan Stoot

10:45

L2.1 Minimal Invasive Surgery for gastric cancer

Ewout Kouwenhoven, Almelo, The Netherlands

11:05

L2.2 Image guided surgery and gastric cancer

Alexander Vahrmeijer, Leiden, The Netherlands

11:25

L2.3 Fast track gastric cancer surgery

Shaun Preston, Guildford, UK

11:45

S02 Is there an obesity paradox in gastric cancer patients? - beyond BMI

Hugo Santos-Sousa, Porto, Portugal

11:55

Key note lecture: “The role of immune therapy in gastric cancer”

Florian Lordick, Leipzig, Germany

12:25

Lunch

Session 3 Pathhology

Chairs : Nicole van Grieken & Heike Grabsch

13:15

L3.1 Grading of histopathological response after neoadjuvant treatment in gastric cancer

Rupert Langer, Bern, Switzerland

13:35

L3.2 Clinical relevance of molecular biomarkers

Nicole van Grieken, Amsterdam, The Netherlands

13:55

L3.3 Advances in tissue-based biomarkers of response to immunotherapy for gastric cancer

Christoph Roecken, Kiel, Germany

14:15

S03 High lymphoid infiltration as prognostic factor in submucosal penetrating EGC

Mattia Berselli, Varese, Italy

14:25

Break

Session 4 Multimodality 1

Chairs: Florian Lordick & Marije Slingerland

15:05

L4.1 Results from the CRITICS trial

Annemieke Cats, Amsterdam, The Netherlands

15:25

L4.2 Results from the FLOT trial

Stefan Moenig, Geneve, Switserland

15:45

L4.3 Results from the MAGIC B / ST03 trial

Lizzy Smyth, London, UK

16:05

S04 Evaluation of the Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in gastric cancer patients with peritoneal carcinomatosis

René Thieme, Leipzig, Germany

Session 5 EURECCA

Chairs: Cornelis van de Velde & Bill Allum

16:15

L5.1 Care for frail and elderly gastric cancer patients

Marilia Cravo, Loures, Portugal

16:35

L5.2 European comparison of treatment strategy and survival in older (=70 years) patients with resectable gastric cancer (EURECCA)

Yvette Claassen, Leiden, The Netherlands

16:45

L5.3 Treatment of gastric cancer in the Elderly: The Verona / RMH review

Valentina Mengardo, Verona, Italy

16:55

L5.4 International comparison of treatment strategy and survival in metastatic gastric cancer (EURECCA)

Wobbe de Steur, Leiden, The Netherlands

17:05

L5.5 Can oligometastatic gastric cancer be cured?

Stefan Moenig, Geneve, Switserland

17:25

Drinks

19:00

Dinner

Friday 08 Jun

Friday 08 June 2018

08:30

Registration

Session 6 Quality of care

Chairs: Shaun Preston & Suzanne Gisbertz

09:00

L6.1 Prospective clinical data and quality of life registration of esophagogastric cancer patients in the Netherlands: first results of the POCOP project

Hanneke van Laarhoven, Amsterdam, The Netherlands

09:20

L6.2 National Auditing

Bas Wijnhoven, Rotterdam, The Netherlands

09:40

L6.3 Essential requirements for quality care in oesophagogastric cancer

Bill Allum, London, England

10:00

S06 The GASTROS Study: Standardising Outcomes Reporting in Surgical Trials for Gastric Cancer; An Update

Bilal Alkhaffaf, Manchester, UK

10:10

Break

Session 7 Multimodality 2

Chairs: Elizabeth Smyth & Hanneke van Laarhoven

10:40

L7.1 The CRITICS 2 trial

Marcel Verheij, Amsterdam, The Netherlands

11:00

L7.2 Chemotherapy in poorly differentiated tumours

Guillaume Piessen, Lille, France

11:20

L7.3 The role of HIPEC in gastric cancer

Johanna van Sandick, Amsterdam, The Netherlands

11:40

S07 Treatment of peritoneal metastases from gastric carcinoma: experience from Central-Eastern Europe

Wojciech Polkowski, Lublin, Poland

11:50

The role of targeted therapy in advanced gastric cancer

Optimizing treatment sequencing to improve patient outcomes

12:50

Lunch

13:15

Keynote lecture: Minimal-invasive Gastrectomy: What the West can learn from the East

Han-Kwang Yang, Seoul, Korea

Session 8 Surgery 2

Chairs: Stefan Moenig & Bas Wijnhoven

14:00

L8.1 Surgicopathological quality in the CRITICS gastric cancer trial

Yvette Claassen, Leiden, The Netherlands

14:20

L8.2 The surgical management in advanced gastric cancer

Franco Roviello, Sienna, Italy

14:40

L8.3 Palliative surgery for gastric cancer

Henk Hartgrink, Leiden, The Netherlands

15:00

S08 Root-cause analysis of serious adverse events after surgery for gastric cancer

Charlotte Cords, Rotterdam, The Netherlands

15:10

Break

Session 9 Outcomes of surgery

Chairs; Bill Allum & Hans Meyer

15:40

L9.1 Centralisation in gastic cancer

Daniel Kjaer, Denmark

16:00

L9.2 Regional and hospital variation in gastric cancer treatment

Rob Verhoeven, IKNL, The Netherlands

16:20

L9.3 Complications in gastric cancer surgery

Gian Luca Baiocchi, Brescia, Italy

16:40

Adjourn